Cincinnati Enquirer: 'Don't panic.' Anti-diabetes medication recalled, may contain high levels of cancer-causing compound
UC diabetes experts offers advice for patients in wake of recall
Two pharmaceutical companies issued voluntary recalls Monday for metformin, an anti-diabetes drug, due to high levels of a cancer-causing compound, according to the U.S. Food and Drug Administration. Metformin is used to treat type 2 diabetes, according to Mayo Clinic, and is distributed under the following brand names: Fortamet, Glucophage, Glucophage XR, Glumetza and Riomet.
The Cincinnati Enquirer spoke with Dr. Shailendra Patel, a professor and director of the UC Division of Endocrinology, Diabetes and Metabolism and UC Health physician, about the recall. He offered a message for patients who use metformin: do not quite the drug cold turkey.
"Don't panic," Patel told the Enquirer. "Just have a nice discussion with your provider. And make sure that if the medication's the only thing that's controlling your disease, don't stop it. Just go in and ask and say, 'what are my alternatives?' "
Read the full story in the Cincinnati Enquirer.
Learn more about Dr. Shailendra Patel.
Featured photo of blood sugar management device and generic medication courtesy of Unsplash.
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Dual-arm robot stabilizes satellite for repairs in space
March 13, 2026
Interesting Engineering highlights an aerospace engineering research project examining novel ways to keep repair robots oriented in space.
Scientists discover how snakes stand upright without limbs
March 12, 2026
Earth.com highlights a study co-authored by UC Professor Bruce Jayne, an expert in snake locomotion, about how snakes stand upright without arms or legs.